Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleNovel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.AuthorsZhang, Yingshi; Li, Dandan; Jiang, Qiyu; Cao, Shuang; Sun, Huiwei; Chai, Yantao; Li, Xiaojuan; Ren, Tianshu; Yang, Ruichuang; Feng, Fan; Li, Bo-an; Zhao, QingchunPublicationCell Death & Disease, 2018, Vol 9, Issue 7, p1ISSN2041-4889Publication typeArticleDOI10.1038/s41419-018-0804-6